Brief: FDA Approves Advancement Of Ppp001 Clinical Trial Previously Discontinued

Tetra Bio Pharma

25/11/2019 17:53

Nov 25 (Reuters) - Tetra Bio Pharma Inc  TBP.V :
    * FDA APPROVES ADVANCEMENT OF PPP001 CLINICAL TRIAL
PREVIOUSLY
DISCONTINUED
    * TETRA BIO PHARMA - HAS BEGUN ACTIVITIES TO RESUME
PLENITUDE
CLINICAL TRIAL PROGRAM & PLANS TO INITIATE ENROLLMENT AS QUICKLY
AS POSSIBLE
    * TETRA BIO PHARMA INC - ACCELERATING PLANS TO SIGN
COMMERCIAL
PARTNER IN U.S. FOR DISTRIBUTION & SALE OF QIXLEEF

Source text for Eikon:  ID:nGNX5VkgT7 
Further company coverage:  TBP.V 

 ((Reuters.Briefs@thomsonreuters.com;))